Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × INDIV × macimorelin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cancer Cachexia 1

Interventions

Proflavine 3 Microbial Collagenase 2 sargramostim 1 pembrolizumab 1 pegfilgrastim 1 macimorelin 1 keyhole-limpet hemocyanin 1 Sodium Chloride 1 Sirolimus 1 Peptides 1 Monatide (IMS 3015) 1 Ipilimumab 1 Gemcitabine 1 Everolimus 1 Bimatoprost 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01614990 2024-03-20

Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia

Garcia, Jose M., MD, PhD

Phase 2 Completed

15 enrolled 35 charts

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡